{"result": {"id": "5f87d507-f026-47c9-ac2b-0e4f5c69acc2", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Hypertension and Cardiovascular Research Community\",\n    \"summary\": \"This community is centered around hypertension and cardiovascular research, with key entities including JAMA, the JNC7 Report, and the SHEP Cooperative Research Group. These entities are interconnected through publications, research collaborations, and clinical trials, focusing on blood pressure management, stroke prevention, and cardiovascular outcomes. The community's research has significant implications for public health, particularly in managing hypertension and reducing cardiovascular risks.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The high impact severity rating reflects the community's focus on critical health issues like hypertension and cardiovascular diseases, which have widespread public health implications.\",\n    \"findings\": [\n        {\n            \"summary\": \"JAMA as a pivotal entity in hypertension research\",\n            \"explanation\": \"JAMA serves as a central platform for disseminating critical research on hypertension and cardiovascular diseases. It has published influential studies and guidelines, such as the JNC7 guidelines and the SHEP study, which have shaped current understanding and treatment approaches for hypertension. The journal's extensive coverage of clinical trials and research findings underscores its importance in the community. [Data: Entities (2292), Relationships (3814, 3339, +more)]\"\n        },\n        {\n            \"summary\": \"The significance of the JNC7 Report\",\n            \"explanation\": \"The JNC7 Report is a cornerstone in hypertension research, providing comprehensive guidelines for the prevention, detection, evaluation, and treatment of high blood pressure. Its publication in JAMA highlights the collaborative nature of the community and the report's influence on clinical practices worldwide. [Data: Entities (3838), Relationships (3814)]\"\n        },\n        {\n            \"summary\": \"SHEP Cooperative Research Group's contributions\",\n            \"explanation\": \"The SHEP Cooperative Research Group has made significant contributions to understanding the prevention of stroke through antihypertensive drug treatment in older persons with isolated systolic hypertension. Their work, published in JAMA, has been instrumental in advancing stroke prevention strategies. [Data: Entities (3181), Relationships (3339)]\"\n        },\n        {\n            \"summary\": \"Clinical trials on blood pressure management\",\n            \"explanation\": \"Clinical trials such as the CATIS Trial and the BUMP 2 Trial play a crucial role in the community by investigating effective blood pressure management strategies in specific populations, including acute ischemic stroke patients and pregnant individuals with hypertension. These trials contribute valuable data to inform clinical practices. [Data: Entities (3326, 3325), Relationships (3434, 3433)]\"\n        },\n        {\n            \"summary\": \"Research on lipid-modifying therapies\",\n            \"explanation\": \"The community also focuses on lipid-modifying therapies, with entities like the European Atherosclerosis Society Task Force and the CLEAR Wisdom Randomized Clinical Trial exploring treatments such as bempedoic acid for LDL cholesterol reduction. This research is vital for managing cardiovascular risk in high-risk patients. [Data: Entities (4688, 4689), Relationships (4517, 4519)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751560550, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 637, "prompt_tokens": 4890, "total_tokens": 5527, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1728}, "prompt_cache_hit_tokens": 1728, "prompt_cache_miss_tokens": 3162}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n3315,HYPERTENSIVE DISORDER OF PREGNANCY,\"A group of conditions including chronic hypertension, gestational hypertension, and preeclampsia\"\"\",3\n3326,CATIS TRIAL,\"Randomized clinical trial on blood pressure reduction in acute ischemic stroke patients\"\"\",2\n2292,JAMA,\"The **Journal of the American Medical Association (JAMA)** is a high-impact medical journal that publishes clinical research, including randomized controlled trials and studies on a wide range of health topics. It is recognized for its contributions to hypertension research, having published influential reports such as the **JNC7 guidelines** and studies like the **SHEP study**, which examined blood pressure management in various populations. JAMA has also featured research on **blood pressure reduction in acute ischemic stroke**, **recurrent stroke prevention**, and the **association of office and ambulatory blood pressure with mortality and cardiovascular outcomes (2019)**.  \n\nAdditionally, JAMA has covered studies on **heart failure**, including a 2013 investigation into the effect of **aliskiren** on postdischarge mortality and readmissions. The journal has also explored **dementia**, **diabetes**, and **dietary cholesterol**, as well as clinical trials such as the **STEP 8 trial** and the **CLEAR Wisdom Randomized Clinical Trial**.  \n\nOverall, JAMA serves as a leading platform for disseminating critical medical research, with a strong emphasis on **hypertension control**, **cardiovascular outcomes**, and broader clinical advancements.\",17\n3838,JNC7 REPORT,\"The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure\",3\n3181,SHEP COOPERATIVE RESEARCH GROUP,\"A research group that studied the prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension\"\"\",2\n2481,WILLIAMSON JD,\"**WILLIAMSON JD** is a researcher associated with the **SPRINT Research Group**, where he is involved in conducting a randomized trial comparing intensive versus standard blood-pressure control. His work specifically focuses on studying the effects of these blood-pressure control strategies in elderly adults. This research contributes to understanding the optimal approaches for managing blood pressure in older populations.\",2\n3343,CATIS,,2\n3184,PERRY HM JR,\"Author of a study on the effect of treating isolated systolic hypertension on stroke risk, published in JAMA in 2000\"\"\",1\n3366,HUGHES D,\"Researcher who studied blood pressure lowering and dementia risk\"\"\",1\n3848,GREEN BB,A researcher studying the effectiveness of home blood pressure monitoring and pharmacist care,1\n4580,ZHONG VW,\"Co-author of a study on dietary cholesterol or egg consumption and cardiovascular disease\"\"\",1\n4684,EUROPEAN ATHEROSCLEROSIS SOCIETY TASK FORCE,\"A task force providing guidance on lipid-modifying therapy\"\"\",3\n4688,BEMPEDOIC ACID,Bempedoic acid is a pharmaceutical agent studied for its effects on LDL cholesterol in high-risk patients. It was investigated in the CLEAR Wisdom Randomized Clinical Trial to evaluate its efficacy and safety in managing cholesterol levels. The drug represents a potential therapeutic option for individuals at elevated cardiovascular risk.,4\n4689,CLEAR WISDOM RANDOMIZED CLINICAL TRIAL,\"A clinical trial evaluating the effect of bempedoic acid vs placebo on LDL cholesterol in high-risk cardiovascular patients\"\"\",5\n4685,GOLDBERG AC,\"**GOLDBERG AC** is a researcher involved in studies focused on cardiovascular health, particularly in the context of LDL cholesterol reduction. They participated in the **CLEAR Wisdom Randomized Clinical Trial**, which investigated the efficacy of **bempedoic acid** as a treatment for lowering LDL cholesterol. Their work contributes to advancing understanding and therapeutic options for managing cholesterol-related conditions.\",2\n2465,ETTEHAD D,\"Researcher involved in blood pressure meta-analysis\"\"\",2\n2466,EMDIN CA,\"EMDIN CA is a researcher or author primarily associated with studies related to diabetes and hypertension. Their work includes investigations into blood pressure lowering in individuals with type 2 diabetes, as well as contributions to meta-analyses focusing on blood pressure. EMDIN CA's research appears to center on the intersection of cardiovascular health and metabolic disorders, particularly in the context of diabetes management.\",4\n4670,PEMAFIBRATE,\"A drug studied for triglyceride lowering and cardiovascular risk reduction\"\"\",3\n4686,LEITER LA,\"**LEITER LA** is a researcher involved in a study on bempedoic acid for LDL cholesterol reduction. Specifically, LEITER LA participated in the **CLEAR Wisdom Randomized Clinical Trial**, which investigated the efficacy and safety of bempedoic acid in lowering LDL cholesterol levels. This dual involvement highlights their expertise in cardiovascular research and clinical trials focused on lipid management therapies.\",1\n4687,STROES E,\"STROES E is a researcher involved in a study on bempedoic acid for LDL cholesterol reduction, specifically as part of the CLEAR Wisdom Randomized Clinical Trial. Their work focuses on investigating the efficacy and outcomes of bempedoic acid in managing LDL cholesterol levels within the context of this clinical trial.\",1\n2530,NEAL B,\"**NEAL B** is a researcher primarily focused on studies related to diabetes and hypertension. He has been associated with multiple research projects in these fields, including investigations into the effects of salt substitution on cardiovascular events and mortality. His work underscores his expertise in metabolic and cardiovascular health, particularly in understanding risk factors and interventions for conditions like diabetes and hypertension.\",3\n2531,WU Y,Wu Y is a researcher who studied the effect of salt substitution on cardiovascular events and death>,2\n2532,FENG X,Feng X is a researcher who studied the effect of salt substitution on cardiovascular events and death>,2\n3325,BUMP 2 TRIAL,\"Randomized clinical trial on blood pressure self-monitoring in pregnant individuals with hypertension\"\"\",2\n3323,HE J,\"HE J is a researcher focused on studying the effects of immediate blood pressure reduction in patients with acute ischemic stroke. His work investigates the potential impacts and outcomes of rapid blood pressure management in this specific clinical context. Both descriptions highlight his primary research interest in this area, emphasizing a consistent focus on acute ischemic stroke and blood pressure intervention.\",3\n3504,RAHIMI K,\"RAHIMI K is a researcher primarily associated with studies on diabetes and hypertension, with a specific focus on blood pressure management in individuals with type 2 diabetes. Their work involves investigating the effects of blood pressure-lowering treatments and their implications for patients with this condition. As an author or contributor to related research, RAHIMI K plays a role in advancing understanding and treatment strategies for these interconnected health issues.\",1\n3544,STEP 8,STEP 8 is a randomized clinical trial comparing the effects of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes,4\n3550,RUBINODM,RubinoDM is a researcher involved in the STEP 8 trial,1\n3551,GREENWAYFL,GreenwayFL is a researcher involved in the STEP 8 trial,1\n3552,KHALIDU,KhalidU is a researcher involved in the STEP 8 trial,1\n4666,HEDAN TABLET,\"A Chinese medicinal product studied for its effects on lipid profiles\"\"\",2\n3319,CHAPPELL LC,\"Researcher studying blood pressure self-monitoring in pregnant individuals with hypertension\"\"\",2\n3837,CHOBIANIAN AV,\"A researcher involved in the JNC7 report on hypertension prevention, detection, evaluation, and treatment\",1\n4667,DAS PRADHAN A,\"A researcher involved in a study on pemafibrate for cardiovascular risk reduction\"\"\",1\n4681,AVERNA M,\"A researcher involved in a European Atherosclerosis Society Task Force statement\"\"\",1\n2467,KIRAN A,\"Researcher involved in blood pressure meta-analysis\"\"\",1\n2473,SPRINT RESEARCH GROUP,A research group that conducted a randomized trial of intensive versus standard blood-pressure control,2\n2480,WRIGHT JT,\"Researcher involved in the SPRINT Research Group, conducting a randomized trial of intensive versus standard blood-pressure control\",1\n3191,SYSTOLIC HYPERTENSION IN THE ELDERLY PROGRAM,,1\n4663,XU RX,\"A researcher involved in a study on Hedan Tablet for hyperlipidemia\"\"\",1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n3432,HYPERTENSIVE DISORDER OF PREGNANCY,STROKE,Hypertensive disorders of pregnancy are associated with increased risk of future stroke,30\n3434,STROKE,CATIS TRIAL,Trial investigated blood pressure management in acute ischemic stroke,29\n2530,JAMA,THIJS L,Thijs L co-authored a study published in JAMA,25\n3814,JNC7 REPORT,JAMA,The JNC7 report was published in JAMA,20\n3339,SHEP COOPERATIVE RESEARCH GROUP,JAMA,The SHEP study was published in JAMA,19\n3378,WILLIAMSON JD,JAMA,Williamson JD published research in JAMA on blood pressure control in elderly adults.,19\n3438,JAMA,CATIS,The CATIS trial was published in JAMA,19\n3341,JAMA,PERRY HM JR,Perry HM Jr's study was published in JAMA,18\n3463,JAMA,HUGHES D,Published meta-analysis on blood pressure lowering in JAMA,18\n3816,JAMA,GREEN BB,Green BB published research in JAMA on hypertension control,18\n4454,ZHONG VW,JAMA,Zhong VW co-authored research published in JAMA,18\n4517,EUROPEAN ATHEROSCLEROSIS SOCIETY TASK FORCE,BEMPEDOIC ACID,The task force provided guidance on lipid-modifying therapies including bempedoic acid,7\n4519,CLEAR WISDOM RANDOMIZED CLINICAL TRIAL,GOLDBERG AC,Goldberg AC was a researcher in the CLEAR Wisdom Randomized Clinical Trial,7\n2650,ETTEHAD D,EMDIN CA,Co-authors of a blood pressure meta-analysis,6\n4508,PEMAFIBRATE,EUROPEAN ATHEROSCLEROSIS SOCIETY TASK FORCE,The task force provided guidance on lipid-modifying therapies including pemafibrate,6\n4514,ICOSAPENT ETHYL,BEMPEDOIC ACID,Both are drugs studied for cardiovascular risk reduction,6\n4518,GOLDBERG AC,BEMPEDOIC ACID,Goldberg AC studied the effects of bempedoic acid on LDL cholesterol,6\n4520,CLEAR WISDOM RANDOMIZED CLINICAL TRIAL,LEITER LA,Leiter LA was a researcher in the CLEAR Wisdom Randomized Clinical Trial,6\n4521,CLEAR WISDOM RANDOMIZED CLINICAL TRIAL,STROES E,Stroes E was a researcher in the CLEAR Wisdom Randomized Clinical Trial,6\n2702,NEAL B,WU Y,Neal B and Wu Y collaborated on a study about salt substitution and cardiovascular events,5\n2703,NEAL B,FENG X,Neal B and Feng X collaborated on a study about salt substitution and cardiovascular events,5\n3433,HYPERTENSIVE DISORDER OF PREGNANCY,BUMP 2 TRIAL,Trial focused on blood pressure management in hypertensive pregnancies,5\n3436,HE J,CATIS TRIAL,He J was a lead researcher in this clinical trial,5\n3557,EMDIN CA,RAHIMI K,Co-authors of research on diabetes and hypertension,5\n3588,STEP 8,RUBINODM,RubinoDM is a researcher involved in the STEP 8 trial,5\n3589,STEP 8,GREENWAYFL,GreenwayFL is a researcher involved in the STEP 8 trial,5\n3590,STEP 8,KHALIDU,KhalidU is a researcher involved in the STEP 8 trial,5\n4506,HEDAN TABLET,PEMAFIBRATE,Both are drugs studied for lipid profile improvement,5\n2704,WU Y,FENG X,Wu Y and Feng X collaborated on a study about salt substitution and cardiovascular events,4\n3435,CHAPPELL LC,BUMP 2 TRIAL,Chappell LC was a lead researcher in this clinical trial,4\n3813,CHOBIANIAN AV,JNC7 REPORT,Chobanian AV was involved in the JNC7 report on hypertension,4\n4507,DAS PRADHAN A,PEMAFIBRATE,Das Pradhan A researched the effects of pemafibrate on cardiovascular risk,4\n4516,AVERNA M,EUROPEAN ATHEROSCLEROSIS SOCIETY TASK FORCE,Averna M was part of the European Atherosclerosis Society Task Force,4\n2651,ETTEHAD D,KIRAN A,Co-authors of a blood pressure meta-analysis,3\n2657,SPRINT RESEARCH GROUP,WRIGHT JT,Wright JT is a researcher involved in the SPRINT Research Group,3\n3340,SHEP COOPERATIVE RESEARCH GROUP,SYSTOLIC HYPERTENSION IN THE ELDERLY PROGRAM,The SHEP Cooperative Research Group conducted the Systolic Hypertension in the Elderly Program,3\n4505,XU RX,HEDAN TABLET,Xu RX studied the effects of Hedan Tablet on lipid profiles,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_ef537e1c85bd8db8cf1b52aa9484cc9a362e50f071dffb2874385855fbdece6b_v2"}